• CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Clinical and Laboratory Standards Institute, 03/01/2017

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/03/2017

Pages:70

File Size:1 file , 2.9 MB

Note:This product is unavailable in Russia, Belarus

This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

More CLSI standard pdf

CLSI I/LA20

CLSI I/LA20

Analytical Performance Characteristics, Quality Assurance, and Clinical Utility of Immunological Assays for Human Immunoglobulin E Antibodies of Defined Allergen Specificities, 3rd Edition, ILA20Ed3E

$90.00 $180.00

CLSI QMS24 (R2021)

CLSI QMS24 (R2021)

Using Proficiency Testing and Alternative Assessment to Improve Medical Laboratory Quality, QMS24Ed3E

$90.00 $180.00

CLSI C24

CLSI C24

Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions; C24Ed4E

$103.00 $207.00

CLSI M45

CLSI M45

Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Third Edition, M45Ed3EA2E

$90.00 $180.00